Skip to content

Integer Holdings ITGR Stock-Based Comp

Stock-Based Comp at other companies

TFX
TeleflexTFX
$6.74M+1.7%
TE Connectivity logo
TE ConnectivityTEL
$42M+23.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%
LivaNova logo
LivaNovaLIVN
$8.27M+6.3%
Boston Scientific logo
Boston ScientificBSX
$83M+12.2%
Medtronic logo
MedtronicMDT
$95M+6.7%

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$3.04B-27.0%
Enterprise value$4.41B-19.6%
P/E21.4×-32.8×
P/S1.6×-0.7×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Integer Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integer Holdings's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integer Holdings's stock-based comp?
Integer Holdings (ITGR) reported stock-based comp of $6.66M in Q1 2026.
How has Integer Holdings's stock-based comp changed year-over-year?
Integer Holdings's stock-based comp decreased by 3.2% year-over-year, from $6.88M to $6.66M.
What is the long-term trend for Integer Holdings's stock-based comp?
Over 4 years (2021 to 2025), Integer Holdings's stock-based comp has grown at a 9.4% compound annual growth rate (CAGR), from $16.19M to $23.22M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.